IP Library › Assignment 066377/0741

Patent Assignment

Reel/Frame 066377/0741

Termination and Release of Security Interest in Patents

Recorded: 2024-01-29 Pages: 27

View PDF Order Certified Copy

Assignor

BIOPHARMA CREDIT PLC

Executed: 2024-01-26

Assignees

AKEBIA THERAPEUTICS, INC.

245 FIRST STREET, CAMBRIDGE, MASSACHUSETTS, 02142

KERYX BIOPHARMACEUTICALS, INC.

245 FIRST STREET, CAMBRIDGE, MASSACHUSETTS, 02142

Covered Properties (46)

Ferric Citrate Dosage Forms

Application: 16/376,907 →

Publication: US 2020/0215019

Use of Ferric Citrate in the Treatment of Chronic Kidney Disease Patients

Application: 16/154,268 →

Publication: US 2019/0269645

Use of Ferric Citrate in the Treatment of and the Reduction of Mortality and Morbidity Related to Adverse Cardiac Events in Chronic Kidney Disease Patients

Application: 16/216,772 →

Publication: US 2019/0307791

Use of Ferric Citrate in the Treatment of Iron-Deficiency Anemia

Application: 15/553,348 →

Publication: US 2018/0071243

Tablet Containing Ferric Citrate

Application: 16/438,694 →

Publication: US 2020/0163890

Ferric Organic Compounds, Uses Thereof and Methods of Making Same

Application: 16/589,905 →

Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof and Methods of Making Same

Application: 16/352,455 →

Publication: US 2019/0269722

Iron (Iii) Citrate, Substantially Free of Beta-Iron Hydroxide Oxide

Application: 15/449,132 →

Publication: US 2018/0016220

Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof and Methods of Making Same

Application: 16/832,101 →

Ferric Citrate Dosage Forms

Application: 16/894,121 →

Publication: US 2020/0297689

Ferric Organic Compounds, Uses Thereof and Methods of Making Same

Application: 16/885,471 →

Iron (Iii) Citrate, Substantially Free of Beta-Iron Hydroxide Oxide

Application: 16/815,472 →

Publication: US 2021/0032186

Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof and Methods of Making Same

Application: 17/091,090 →

Publication: US 2021/0299168

Ferric Organic Compounds, Uses Thereof and Methods of Making Same

Application: 17/141,765 →

Method of Treating Chronic Kidney Disease

Application: 17/119,554 →

Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof and Methods of Making Same

Application: 17/350,267 →

Publication: US 2022/0144872

Ferric Organic Compounds, Uses Thereof and Methods of Making Same

Application: 17/405,543 →

Publication: US 2022/0213133

Method of Treating Chronic Kidney Disease

Application: 17/388,361 →

Publication: US 2022/0193022

Use of Ferric Citrate in the Treatment of Iron-Deficiency Anemia

Application: 17/490,195 →

Use of Ferric Citrate in the Treatment of Iron-Deficiency Anemia

Application: 17/743,196 →

Pediatric Formulations of Ferric Citrate

Application: 63/193,938 →

Method of Treating Chronic Kidney Disease

Application: 18/123,053 →

Use of Ferric Citrate in the Treatment of Chronic Kidney Disease Patients

Application: 18/147,240 →

Publication: US 2024/0041816

Use of Ferric Citrate in the Treatment of Iron-Deficiency Anemia

Application: 18/069,555 →

Publication: US 2024/0075006

Use of Ferric Citrate in the Treatment of and the Reduction of Mortality and Morbidity Related to Adverse Cardiac Events in Chronic Kidney Disease Patients

Application: 18/107,928 →

Ferric Organic Compounds, Uses Thereof and Methods of Making Same

Patent: 7,767,851 →

Application: 11/206,981 →

Publication: US 2006/0020026

Ferric Organic Compounds, Uses Thereof and Methods of Making Same

Patent: 8,338,642 →

Application: 12/711,679 →

Publication: US 2010/0217025

Ferric Organic Compounds, Uses Thereof and Methods of Making Same

Patent: 8,609,896 →

Application: 13/672,900 →